dichlororibofuranosylbenzimidazole has been researched along with topotecan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaufmann, SH | 1 |
| Buckwalter, CA; Cheng, YC; Kaufmann, SH; Lin, AH; Pommier, YG; Tanizawa, A | 1 |
2 other study(ies) available for dichlororibofuranosylbenzimidazole and topotecan
| Article | Year |
|---|---|
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Topics: Amsacrine; Aphidicolin; Blotting, Western; Camptothecin; Colony-Forming Units Assay; Cycloheximide; Daunorubicin; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA Polymerase II; DNA Replication; Drug Synergism; Etoposide; Female; Humans; Leukemia, Promyelocytic, Acute; Mutagens; RNA; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured | 1991 |
RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I.
Topics: Animals; Camptothecin; Cell Nucleus; Cricetinae; Dichlororibofuranosylbenzimidazole; DNA Topoisomerases, Type I; Humans; Mice; RNA; Topotecan; Tumor Cells, Cultured | 1996 |